mdl-201112 has been researched along with dinoprostone in 1 studies
Studies (mdl-201112) | Trials (mdl-201112) | Recent Studies (post-2010) (mdl-201112) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
10 | 0 | 0 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | mdl-201112 (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Humidan, A; Al-Sedairy, ST; Al-Sofi, A; Dzimiri, M; Edwards, CK; Khabar, KS | 1 |
1 other study(ies) available for mdl-201112 and dinoprostone
Article | Year |
---|---|
A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline.
Topics: Adenine; Dinoprostone; Humans; Immunosuppressive Agents; Interleukin-8; Isoantigens; Leukocytes, Mononuclear; Lymphocyte Culture Test, Mixed; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Superantigens; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1998 |